应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
09996 沛嘉医疗-B
午间休市 02-27 12:05:00
5.820
+0.020
+0.34%
最高
5.830
最低
5.740
成交量
13.30万
今开
5.830
昨收
5.800
日振幅
1.55%
总市值
39.11亿
流通市值
39.11亿
总股本
6.72亿
成交额
76.83万
换手率
0.02%
流通股本
6.72亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
国家药监局：2025年共收到创新医疗器械特别审批申请457项
金吾财讯 · 11:30
国家药监局：2025年共收到创新医疗器械特别审批申请457项
三诺生物（300298）披露取得五项医疗器械注册证暨注册变更公告，2月26日股价下跌1.54%
证券之星 · 02-26 22:45
三诺生物（300298）披露取得五项医疗器械注册证暨注册变更公告，2月26日股价下跌1.54%
锦波生物（920982）披露获得马来西亚D类医疗器械注册证公告，2月26日股价下跌0.23%
证券之星 · 02-26 22:30
锦波生物（920982）披露获得马来西亚D类医疗器械注册证公告，2月26日股价下跌0.23%
贝康医疗-B(02170)：Geri胚胎培养液(Gems胚胎培养液系列产品之一)获国家药监局颁发医疗器械注册证
智通财经 · 02-26 18:51
贝康医疗-B(02170)：Geri胚胎培养液(Gems胚胎培养液系列产品之一)获国家药监局颁发医疗器械注册证
沛嘉医疗-B盘中异动 大幅跳水5.26%报5.760港元
市场透视 · 02-26 14:19
沛嘉医疗-B盘中异动 大幅跳水5.26%报5.760港元
每日卖空追踪 | 沛嘉医疗-B 02月25日卖空量成交4000股，卖空比例为1.24%
市场透视 · 02-25 16:30
每日卖空追踪 | 沛嘉医疗-B 02月25日卖空量成交4000股，卖空比例为1.24%
2025消费大复盘：万店不稀罕，千亿才刚及格
蓝鲸财经 · 02-25 14:46
2025消费大复盘：万店不稀罕，千亿才刚及格
敷尔佳（301371）披露第三类医疗器械产品完成临床试验公告，2月24日股价上涨0.12%
证券之星 · 02-24 18:49
敷尔佳（301371）披露第三类医疗器械产品完成临床试验公告，2月24日股价上涨0.12%
安图生物（603658）披露公司及全资子公司获得医疗器械注册证的公告，2月24日股价上涨0.3%
证券之星 · 02-24 18:22
安图生物（603658）披露公司及全资子公司获得医疗器械注册证的公告，2月24日股价上涨0.3%
每日卖空追踪 | 沛嘉医疗-B 02月24日卖空量成交2.6万股，卖空比例为5.75%
市场透视 · 02-24 16:30
每日卖空追踪 | 沛嘉医疗-B 02月24日卖空量成交2.6万股，卖空比例为5.75%
每日卖空追踪 | 沛嘉医疗-B 02月20日卖空量成交1万股，卖空比例为1.99%
市场透视 · 02-20
每日卖空追踪 | 沛嘉医疗-B 02月20日卖空量成交1万股，卖空比例为1.99%
港股异动 | 微创心通-B(02160)涨超6% 植入式心律转复除颤器进入创新医疗器械特别审查程序
智通财经网 · 02-16
港股异动 | 微创心通-B(02160)涨超6% 植入式心律转复除颤器进入创新医疗器械特别审查程序
微创心通-B(02160)：植入式心律转复除颤器进入创新医疗器械特别审查程序
智通财经 · 02-13
微创心通-B(02160)：植入式心律转复除颤器进入创新医疗器械特别审查程序
中生北控生物科技(08247)附属中生医疗自主研发的BioCyte 系列流式细胞仪获发马来西亚医疗器械注册证
智通财经 · 02-13
中生北控生物科技(08247)附属中生医疗自主研发的BioCyte 系列流式细胞仪获发马来西亚医疗器械注册证
心力衰竭医疗器械开发商BioVentrix(BVXX.US)申请在美IPO 拟募资1700万美元
智通财经 · 02-13
心力衰竭医疗器械开发商BioVentrix(BVXX.US)申请在美IPO 拟募资1700万美元
每日卖空追踪 | 沛嘉医疗-B 02月11日卖空量成交9000股，卖空比例为1.26%
市场透视 · 02-11
每日卖空追踪 | 沛嘉医疗-B 02月11日卖空量成交9000股，卖空比例为1.26%
沛嘉医疗-B02月11日主力净流出80.1万元 散户资金买入
市场透视 · 02-11
沛嘉医疗-B02月11日主力净流出80.1万元 散户资金买入
创新放量，交易升温！中国创新医疗器械发展迈入新阶段
制药网 · 02-11
创新放量，交易升温！中国创新医疗器械发展迈入新阶段
每日卖空追踪 | 沛嘉医疗-B 02月10日卖空量成交6000股，卖空比例为1.52%
市场透视 · 02-10
每日卖空追踪 | 沛嘉医疗-B 02月10日卖空量成交6000股，卖空比例为1.52%
广西北海市开展春节前医疗器械监督检查
中国质量新闻网 · 02-09
广西北海市开展春节前医疗器械监督检查
加载更多
公司概况
公司名称：
沛嘉医疗-B
所属市场：
SEHK
上市日期：
--
主营业务：
沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部，经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。
发行价格：
--
{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":5.82,"timestamp":1772165100009,"preClose":5.8,"halted":0,"volume":133000,"delay":0,"changeRate":0.0034482758620690453,"floatShares":672000000,"shares":672000000,"eps":-0.338431,"marketStatus":"午间休市","change":0.02,"latestTime":"02-27 12:05:00","open":5.83,"high":5.83,"low":5.74,"amount":768310,"amplitude":0.015517,"askPrice":5.84,"askSize":6000,"bidPrice":5.8,"bidSize":16000,"shortable":3,"etf":0,"ttmEps":-0.372288,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772168400000},"marketStatusCode":3,"adr":0,"listingDate":1589472000000,"exchange":"SEHK","adjPreClose":5.8,"openAndCloseTimeList":[[1772155800000,1772164800000],[1772168400000,1772179200000]],"volumeRatio":0.533942,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996","defaultTab":"news","newsList":[{"id":"2614007107","title":"国家药监局：2025年共收到创新医疗器械特别审批申请457项","url":"https://stock-news.laohu8.com/highlight/detail?id=2614007107","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614007107?lang=zh_cn&edition=full","pubTime":"2026-02-27 11:30","pubTimestamp":1772163050,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国家药监局发布2025年度创新医疗器械等产品注册审批情况，2025年，国家药监局按照《创新医疗器械特别审查程序》《医疗器械优先审批程序》继续做好相关产品的审查工作，共收到创新医疗器械特别审批申请457项，其中104项获准进入创新医疗器械特别审查程序；收到优先申请38项，其中26项获准优先审批。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210625/YjI3NDA0ZDhiMGQ3ZDhlYjY1NzQ2OTEyNjkyMTk4MTc4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YjI3NDA0ZDhiMGQ3ZDhlYjY1NzQ2OTEyNjkyMTk4MTc4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975598","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159883","BK1583","09997","BK1222","BK1574","BK1100","09996"],"gpt_icon":0},{"id":"2614693023","title":"三诺生物（300298）披露取得五项医疗器械注册证暨注册变更公告，2月26日股价下跌1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614693023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614693023?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:45","pubTimestamp":1772117116,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘，三诺生物报收于17.91元，较前一交易日下跌1.54%，最新总市值为100.34亿元。该股当日开盘18.14元，最高18.41元，最低17.88元，成交额达1.39亿元，换手率为1.71%。近日，三诺生物传感股份有限公司获得湖南省药品监督管理局颁发的五项医疗器械注册证和一项医疗器械变更注册文件。上述注册证的取得丰富了公司检测产品线，提升了产品技术性能，有助于增强市场竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK1222","BK1583","BK1574","159883","09997","09996","BK1100","BK0114","BK0251","300298"],"gpt_icon":0},{"id":"2614232028","title":"锦波生物（920982）披露获得马来西亚D类医疗器械注册证公告，2月26日股价下跌0.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614232028","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614232028?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:30","pubTimestamp":1772116237,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘，锦波生物报收于218.99元，较前一交易日下跌0.23%，最新总市值为251.98亿元。该股当日开盘220.0元，最高222.5元，最低217.5元，成交额达9743.33万元，换手率为0.81%。锦波生物于近日获得马来西亚主管当局颁发的一项D类医疗器械注册证，产品为重组Ⅲ型人源化胶原蛋白冻干纤维，品牌名称为AYOUTH，规格包括2mg/瓶至24mg/瓶。注册编号为GD2591526-225199，医疗器械所有人为公司本身，地址位于山西综改示范区太原唐槐园区锦波街18号。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1583","09997","BK1222","BK1574","BK1100","09996"],"gpt_icon":0},{"id":"2614501758","title":"贝康医疗-B(02170)：Geri胚胎培养液(Gems胚胎培养液系列产品之一)获国家药监局颁发医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2614501758","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614501758?lang=zh_cn&edition=full","pubTime":"2026-02-26 18:51","pubTimestamp":1772103109,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贝康医疗-B 发布公告，本公司的Geri胚胎培养液于2026年2月25日获得中国国家药品监督管理局颁发的三类医疗器械注册证。结合Geri湿式时差培养箱与AI胚胎评估系统，Geri胚胎培养液已正式进入中国临床实践，以其抗氧化配方与稳定渗透压环境的两大核心优势，解决了高龄患者胚胎培养的难题。Geri胚胎培养液的技术核心在于针对高龄患者生育难点构建系统性解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK1222","BK1597","BK1583","09997","02170","BK1574","09996","BK1100"],"gpt_icon":0},{"id":"2614713120","title":"沛嘉医疗-B盘中异动 大幅跳水5.26%报5.760港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614713120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614713120?lang=zh_cn&edition=full","pubTime":"2026-02-26 14:19","pubTimestamp":1772086762,"startTime":"0","endTime":"0","summary":"2026年02月26日下午盘14时19分，沛嘉医疗-B股票出现异动，股价快速跳水5.26%。截至发稿，该股报5.760港元/股，成交量50.5万股，换手率0.08%，振幅5.43%。沛嘉医疗-B股票所在的医疗设备及用品行业中，整体跌幅为0.10%。其相关个股中，今海医疗科技、高视医疗、业聚医疗涨幅较大，振幅较大的相关个股有健世科技-B、智云健康、佳兆业健康，振幅分别为12.62%、7.32%、7.07%。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226141922a4ca3304&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226141922a4ca3304&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","09996","BK1100"],"gpt_icon":0},{"id":"2614708399","title":"每日卖空追踪 | 沛嘉医疗-B 02月25日卖空量成交4000股，卖空比例为1.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614708399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614708399?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:30","pubTimestamp":1772008248,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间02月25日，跌2.09%，卖空量成交4000股，较上一交易日减少94.03%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163644a4c6780c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163644a4c6780c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09996","BK1100","BK1583","BK1574"],"gpt_icon":0},{"id":"2614046770","title":"2025消费大复盘：万店不稀罕，千亿才刚及格","url":"https://stock-news.laohu8.com/highlight/detail?id=2614046770","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614046770?lang=zh_cn&edition=full","pubTime":"2026-02-25 14:46","pubTimestamp":1772002010,"startTime":"0","endTime":"0","summary":"六大上市茶饮巨头2025年上半年合计净利润突破55亿元，交出了一份傲人的成绩单。2025年上半年，这家卖4元柠檬水的企业营收148.75亿元，净利润27.18亿元，同比增长44.1%。海外门店达208家，覆盖6个国家，2025年上半年海外GMV同比增长77.4%。截至2025年11月，库迪全国门店总数达15791家，90天内新增2784家，覆盖全国360个城市。以京东七鲜为例，截至2025年10月，七鲜自有品牌商品成交额同比增长445%，SKU数量突破600个，覆盖全品类。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1770969678699708521","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0345775950.USD","HK0000306701.USD","LU1688375341.USD","LKNCY","BK4504","LU0499858438.USD","LU0231483743.USD","BK4614","BK4509","BK4551","BK4579","LU0871576103.HKD","KJD","SG9999002950.SGD","09996","PMRTY","LU0359202008.SGD","LU0211977185.USD","LU0326950275.SGD","BK4505","LU1481107354.HKD","BK4220","LU0244354667.USD","LU0359201885.HKD","09992","LU0593848301.USD","HK0000320223.HKD","IE0034224299.USD","LU0572944931.SGD","BK4524","SG9999001069.SGD","BK4531","IE0008368742.USD","LU0499858602.USD","LU0348767384.USD","BK4122","BK4526","HK0000320264.USD","NNFSF","LU0348766576.USD","SG9999002463.SGD","SGXZ86797644.SGD","IE00BGV7N243.SGD","605499","LU1770036033.HKD","LU0149721374.USD","LU0823426480.USD","LU0345776255.USD","09980","LU0531971595.HKD","SGXZ62798434.SGD","LU0039217434.USD","LU0463099449.HKD","LU2543165471.USD","09633","LU0307460666.USD","BK1224","LU0327786744.USD","LU0611395673.USD","LU1880383366.USD","LU0164865239.USD","BK4558","BK4503","BK4585","LU0588546209.SGD","HK0000306685.HKD","LU1023057109.AUD","LU1188198961.HKD","LU0164880469.USD","LU0823426308.USD","LU0106959298.USD","LU0359201612.USD","BK4588"],"gpt_icon":1},{"id":"2613797713","title":"敷尔佳（301371）披露第三类医疗器械产品完成临床试验公告，2月24日股价上涨0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613797713","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613797713?lang=zh_cn&edition=full","pubTime":"2026-02-24 18:49","pubTimestamp":1771930152,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，敷尔佳报收于24.91元，较前一交易日上涨0.12%，最新总市值为129.56亿元。该股当日开盘25.1元，最高25.24元，最低24.6元，成交额达4956.79万元，换手率为2.57%。公司于近日披露《关于第三类医疗器械产品完成临床试验的公告》。公告显示，哈尔滨敷尔佳科技股份有限公司在研产品“重组Ⅲ型人源化胶原蛋白冻干纤维”已完成临床试验并取得临床试验总结报告，可以进行注册申报材料递交。国内外同类医疗器械产品较少，国内市场潜力较大。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400037704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1574","BK1583","301371","BK1100","BK0229","09997","BK1222","159883"],"gpt_icon":0},{"id":"2613229792","title":"安图生物（603658）披露公司及全资子公司获得医疗器械注册证的公告，2月24日股价上涨0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613229792","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613229792?lang=zh_cn&edition=full","pubTime":"2026-02-24 18:22","pubTimestamp":1771928540,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，安图生物报收于36.29元，较前一交易日上涨0.3%，最新总市值为207.37亿元。该股当日开盘36.24元，最高36.37元，最低36.1元，成交额达6235.5万元，换手率为0.3%。近日，郑州安图生物工程股份有限公司及全资子公司安图实验仪器（郑州）有限公司收到河南省药品监督管理局颁发的医疗器械注册证。上述产品用于体外定量检测人血清或血浆中相应物质含量，或用于对液体中细胞进行多参数快速定量分析。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400036534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK1583","BK0239","BK1222","BK1100","603658","BK1574","09996","159883","BK0046"],"gpt_icon":0},{"id":"2613714551","title":"每日卖空追踪 | 沛嘉医疗-B 02月24日卖空量成交2.6万股，卖空比例为5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613714551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613714551?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:30","pubTimestamp":1771921841,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间02月24日，跌2.2%，卖空量成交2.6万股，较上一交易日减少25.71%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163643a7191edb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163643a7191edb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","09996","BK1574","BK1100"],"gpt_icon":0},{"id":"2613721128","title":"每日卖空追踪 | 沛嘉医疗-B 02月20日卖空量成交1万股，卖空比例为1.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613721128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613721128?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:30","pubTimestamp":1771576241,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间02月20日，涨0.65%，卖空量成交1万股，较上一交易日减少16.67%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163559a70cd199&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163559a70cd199&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09996","BK1583","BK1100"],"gpt_icon":0},{"id":"2611170422","title":"港股异动 | 微创心通-B(02160)涨超6% 植入式心律转复除颤器进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2611170422","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611170422?lang=zh_cn&edition=full","pubTime":"2026-02-16 11:27","pubTimestamp":1771212433,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，微创心通-B涨超6%，截至发稿，涨6.33%，报0.84港元，成交额859.92万港元。消息面上，2月13日晚，微创心通发布公告称，近日，国家药品监督管理局“NMPA”医疗器械技术审评中心发布《创新医疗器械特别审查申请审查结果公示》，拟同意集团旗下新一代植入式心律转复除颤器TILEN/EYLEN 进入创新医疗器械特别审查程序。据此 ，TILEN/EYLEN有望成为国内首款获批的具备自主知识产权的磁共振条件安全ICD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405665.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["09997","VXUS","159883","BK1222","BK1574","BK1583","BK1100","02160","BK4588","VT","BK4585","09996"],"gpt_icon":0},{"id":"2611651851","title":"微创心通-B(02160)：植入式心律转复除颤器进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2611651851","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611651851?lang=zh_cn&edition=full","pubTime":"2026-02-13 23:03","pubTimestamp":1770994990,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创心通-B 发布公告，近日，国家药品监督管理局“NMPA”医疗器械技术审评中心发布《创新医疗器械特别审查申请审查结果公示》，拟同意集团旗下新一代植入式心律转复除颤器TILEN/EYLEN 进入创新医疗器械特别审查程序。此次TILEN/EYLEN进入NMPA绿色通道，有望加速磁共振条件安全ICD的国产化进程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","BK1583","09997","BK1574","BK1100","09996","159883","02160"],"gpt_icon":0},{"id":"2611813478","title":"中生北控生物科技(08247)附属中生医疗自主研发的BioCyte 系列流式细胞仪获发马来西亚医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2611813478","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611813478?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:43","pubTimestamp":1770972201,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中生北控生物科技 发布公告，本公司的附属公司中生(苏州)医疗科技有限公司自主研发的BioCyte 系列流式细胞仪，近日成功通过马来西亚医疗器械管理局的审核，正式获得马来西亚医疗器械注册证，注册编号为IVDA9463526–225393。BioCyte系列流式细胞仪凭藉稳定性能及检测准确性，已在国内市场获得应用。中生医疗依据当地相关法规要求，完成产品检测、技术资料提交及审核程式，最终获得马来西亚医疗器械管理局批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","159883","BK1100","BK1574","159891","BK1222","BK1161","09997","08247","BK1583"],"gpt_icon":0},{"id":"2611313360","title":"心力衰竭医疗器械开发商BioVentrix(BVXX.US)申请在美IPO 拟募资1700万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611313360","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611313360?lang=zh_cn&edition=full","pubTime":"2026-02-13 14:57","pubTimestamp":1770965856,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于研发心力衰竭微创治疗技术的医疗器械公司BioVentrix于周四向美国证券交易委员会提交申请，拟通过首次公开募股筹集至多1700万美元资金。BioVentrix是一家研发并商业化用于治疗射血分数降低型心力衰竭的医疗器械公司。BioVentrix此前曾通过销售Revivent TC经导管心室增强系统获得收入，该产品已于2023年停止销售以节约资金。BioVentrix已于2025年8月5日秘密提交上市申请。本次IPO由The Benchmark Company独家担任账簿管理人，暂未披露发行定价条款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK1574","BK1583","09997","09996","BK1100","BK1222"],"gpt_icon":0},{"id":"2610956825","title":"每日卖空追踪 | 沛嘉医疗-B 02月11日卖空量成交9000股，卖空比例为1.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610956825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610956825?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:30","pubTimestamp":1770798646,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间02月11日，跌2.17%，卖空量成交9000股，较上一交易日减少75.68%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163632a6ee20e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163632a6ee20e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","09996","BK1100","BK1574"],"gpt_icon":0},{"id":"2610956840","title":"沛嘉医疗-B02月11日主力净流出80.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2610956840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610956840?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:15","pubTimestamp":1770797747,"startTime":"0","endTime":"0","summary":"02月11日, 沛嘉医疗-B股价跌2.17%，报收6.30元，成交金额453.5万元，换手率0.11%，振幅4.50%，量比1.15。沛嘉医疗-B今日主力资金净流出80.1万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.33%，主力资金累计净流出34.6万元；近20日主力资金累计净流出543.7万元，其中净流出天数为9日。该股主力净额占比0.02%，港股市场排名2531/2717。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211161952a6ee0ce8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211161952a6ee0ce8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09996","BK1574","BK1100","BK1583"],"gpt_icon":0},{"id":"2610073856","title":"创新放量，交易升温！中国创新医疗器械发展迈入新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2610073856","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610073856?lang=zh_cn&edition=full","pubTime":"2026-02-11 09:54","pubTimestamp":1770774857,"startTime":"0","endTime":"0","summary":"在国家的大力支持下，我国创新医疗器械在近年来发展正突飞猛进。此外，2025年国家药监局公告进入创新医疗器械特别审查程序的产品数量也已高达122款，相比2024年接近翻倍。值得一提的是，随着国产医疗器械创新能力的不断提升，近两年来，中国创新医疗器械收购交易也正逐渐起势。总的来说，中国创新医疗器械产业正处在由大向强转变、换道超车的重要关口期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211095929a495c7e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211095929a495c7e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02190","BK1587","BK1100","BK1222","09997","BK1583","09996","BK1574"],"gpt_icon":0},{"id":"2610678139","title":"每日卖空追踪 | 沛嘉医疗-B 02月10日卖空量成交6000股，卖空比例为1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610678139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610678139?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:30","pubTimestamp":1770712245,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间02月10日，涨0.63%，卖空量成交6000股，较上一交易日减少93.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163629a492bd72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163629a492bd72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1100","09996","BK1583"],"gpt_icon":0},{"id":"2610832633","title":"广西北海市开展春节前医疗器械监督检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2610832633","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610832633?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:51","pubTimestamp":1770627060,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 春节将至，为切实保障群众节日期间用械安全，规范医疗器械市场秩序，近日，广西北海市市场监管部门开展春节前医疗器械质量安全监督检查行动，以强监管、严排查、守底线，守护群众健康过年。行动中，北海市市场监管部门坚持监管与服务并重，推动形成闭环管理。下一步，北海市市场监管部门将持续强化动态巡查，畅通投诉举报渠道，全力守护群众春节期间用械安全，保障人民群众度过平安祥和的新春佳节。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-02-09/doc-inhmfivm6305424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09997","BK1574","159883","BK1100","BK1583","BK1222","09996"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":-0.0538},{"period":"1month","weight":-0.1212},{"period":"3month","weight":0.0861},{"period":"6month","weight":-0.2173},{"period":"1year","weight":0.3395},{"period":"ytd","weight":-0.0349}],"compareEarnings":[{"period":"1week","weight":-0.0122},{"period":"1month","weight":-0.0275},{"period":"3month","weight":0.0202},{"period":"6month","weight":0.052},{"period":"1year","weight":0.109},{"period":"ytd","weight":0.0293}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部，经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.057115},{"month":2,"riseRate":0.5,"avgChangeRate":0.012717},{"month":3,"riseRate":0.4,"avgChangeRate":-0.110838},{"month":4,"riseRate":0.75,"avgChangeRate":0.044776},{"month":5,"riseRate":0.75,"avgChangeRate":-0.061692},{"month":6,"riseRate":0.666667,"avgChangeRate":0.07739},{"month":7,"riseRate":0.5,"avgChangeRate":0.047595},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.086603},{"month":9,"riseRate":0.333333,"avgChangeRate":0.014494},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005393},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.027135},{"month":12,"riseRate":0.666667,"avgChangeRate":0.083675}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}